ロード中...
PPARα inhibition modulates multiple reprogrammed metabolic pathways in kidney cancer and attenuates tumor growth
Kidney cancer [renal cell carcinoma (RCC)] is the sixth-most-common cancer in the United States, and its incidence is increasing. The current progression-free survival for patients with advanced RCC rarely extends beyond 1–2 yr due to the development of therapeutic resistance. We previously identifi...
保存先:
| 出版年: | Am J Physiol Cell Physiol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Physiological Society
2015
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4451352/ https://ncbi.nlm.nih.gov/pubmed/25810260 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1152/ajpcell.00322.2014 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|